Search Results 1601-1610 of 17579 for treatment resistant depression
... treatments and personalize treatment options. Harnessing the ... Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some ...
... Treat Subjects with Relapsed or Refractory Multiple Myeloma and ... therapy, but this study will administer treatment in approximately 3 weeks.
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant · Hidden mutation leads to groundbreaking genetic ...
... refractory (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step ...
... treated with various forms of radiation therapy to improve the treatment of future patients. ... Platinum-resistant/refractory epithelial ovarian, primary ...
Participation eligibility · At least one prior therapy; · Refractory disease on most recent therapy, or disease recurrence following remission on most recent ...
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.